The board of directors of ClouDr Group Limited announced that on December 28, 2023, the Company entered into a non-legally binding strategic cooperation agreement with Shanxi Jinbo Bio-Pharmaceutical Co. Ltd. ("Jinbo Bio-Pharmaceutical"). Pursuant to the Strategic Cooperation Agreement, the Group will be the exclusive general distributor of the sale of selective products of Jinbo Bio-Pharmaceutical in the offline pharmacy channel.

During the term of cooperation, the parties will cooperate in the marketing and promotion, and sales of Jinbo Bio-Pharmaceutical's healthcare products by leveraging the Group's offline pharmacy network. The Group will also provide Jinbo Bio-Pharmaceutical with customized software services by leveraging its technology know-how. Via business cooperation, the parties hope to expand market width and enhance promotion efficiency for Jinbo Bio-Pharmaceutical through digitization, and to provide high-quality healthcare products for pharmacies within the Group's coverage.

The Board considers that the Strategic Cooperation Agreement provides a valuable opportunity to the parties to leverage their respective resources and expertise and create mutual benefits and synergy to each other. Therefore, the Board is of the view that entering into the Strategic Cooperation Agreement is in the interest of the Company and its shareholders as a whole.